Atwoli L, Manguro G, Owiti P, Ndambuki D
Department of Psychiatry, Moi University, School of Medicine, P.O Box 4606-30100, Eldoret, Kenya.
East Afr Med J. 2009 Jul;86(7):354-6. doi: 10.4314/eamj.v86i7.54153.
In this case, a thirty six year old patient on treatment for schizophrenia is described with severe tardive dyskinesia. The most likely cause is long term treatment with two highly potent typical antipsychotic medications. The patient was initially treated with Benzhexol, an anticholinergic agent with the potential to induce or aggravate the disorder. This case discusses the common presentation and management of neuroleptic induced tardive dyskinesia.
在本病例中，描述了一名36岁正在接受精神分裂症治疗的患者患有严重的迟发性运动障碍。最可能的原因是长期使用两种高效的典型抗精神病药物进行治疗。该患者最初接受苯海索治疗，这是一种具有诱发或加重该疾病可能性的抗胆碱能药物。本病例讨论了抗精神病药物所致迟发性运动障碍的常见表现及管理。
